Skip to main content

Featured

More HZMB private car quotas set

The governments of Hong Kong and Macau have agreed to increase the regular quotas for Hong Kong cross-boundary non-commercial private cars using the Hong Kong-Zhuhai-Macao Bridge to Macau, the Transport Department announced today.   The decision was made to enhance traffic flow between Hong Kong and Macau, better utilising the bridge, the department said.   It will increase the Hong Kong quota by 1,000, following the earlier quota allocation of 1,800 for Hong Kong.   The additional quota will be distributed in two phases from the second quarter.   Half of the additional 1,000 quota allocations is for company applicants and the other half is for individual applicants. The quotas are valid for no more than three years. The eligibility criteria of quota applications remains the same.   Private cars allocated with Hong Kong quotas will be permitted to access the city of Macau multiple times using the bridge.   The Hong Kong quota allotments will be re-allocated upon expiry thro

Vaccination cases assessed

The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation assessed three death cases with history of vaccination during its meeting today.       As of April 4, the Department of Health received a total of 15 death reports with history of COVID-19 immunisation from the Hospital Authority.   The cases involve 11 men and four women aged between 55 and 80. Existing information indicates that most of these cases died of cardiovascular diseases.   Three of the cases were assessed in today's meeting.   The first case involves a 67-year-old man who passed away on March 13. The full autopsy report indicated that the patient died of acute myocardial infarction due to coronary atherosclerosis, while other investigations did not reveal possible immunological reactions due to a vaccine.   The committee considered that there was no causal relationship between the deceased's outcome and COVID-19 vaccination.   The second case involves a 68-year-old woman with hypertension, hypothyroidism and lipid disorder who passed away on March 29 and received a dose of CoronaVac 26 days before her death.   Based on the preliminary autopsy findings of acute myocardial infarction, the committee considered that the deceased's outcome was not directly associated with COVID-19 vaccination.   The last case involves a 62-year-old man with a history of newly diagnosed hypertension who passed away on April 2 and received a dose of CoronaVac 25 days prior to his death. The causality assessment will be conducted when preliminary autopsy findings are available.
http://dlvr.it/RxBS5n

Popular Posts